Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 46, 2013, Pages

  Rylander, Daniella ^a,b   Bagetta, Vincenza ^b   Pendolino, Valentina ^b   Zianni, Elisa ^c   Grealish, Shane ^a   Gardoni, Fabrizio ^c   Di Luca, Monica ^c   Calabresi, Paolo ^b,d   Cenci, M Angela ^a   Picconi, Barbara ^b  

^a LUND UNIVERSITY   (Sweden)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

5 HT; 6 OHDA lesion; DA; LTD; LTP

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DOPAMINE; DOPAMINE 1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DORSOLATERAL STRIATUM; DRUG EFFECT; EMBRYO; FEMALE; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REINNERVATION; SEROTONINERGIC NERVE CELL; VENTROLATERAL STRIATUM;

5-HT; 6-OHDA LESION; DA; LTD; LTP;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; EMBRYO, MAMMALIAN; FEMALE; IMMUNOHISTOCHEMISTRY; LONG-TERM POTENTIATION; MOTOR ACTIVITY; NEURONAL PLASTICITY; PARKINSONIAN DISORDERS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84887480169     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311187110     Document Type: Article

References (76)

1. Winkler C, Bentlage C, Nikkhah G, Samii M, Björklund A (1999) Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol 155(2):165-186. (Pubitemid 29124711)
2. Lindvall O, et al. (1994) Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35(2):172-180. (Pubitemid 24050152)
3. Cenci MA, Campbell K, Björklund A (1993) Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience 57(2):275-296. (Pubitemid 23345298)
4. Freund TF, et al. (1985) Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: A tyrosine hydroxylase immunocytochemical study. J Neurosci 5(3):603-616. (Pubitemid 15100450)
5. Doucet G, et al. (1989) Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Exp Neurol 106(1):1-19. (Pubitemid 19246445)
6. Arbuthnott G, Dunnett S, MacLeod N (1985) Electrophysiological properties of single units in dopamine-rich mesencephalic transplants in rat brain. Neurosci Lett 57(2): 205-210. (Pubitemid 15058300)
7. Tønnesen J, et al. (2011) Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS ONE 6(3):e17560.
8. Calabresi P, et al. (2000) Synaptic transmission in the striatum: From plasticity to neurodegeneration. Prog Neurobiol 61(3):231-265. (Pubitemid 30155721)
9. Calabresi P, Picconi B, Tozzi A, Di Filippo M (2007) Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30(5):211-219. (Pubitemid 46654232)
10. Calabresi P, Maj R, Pisani A, Mercuri NB, Bernardi G (1992) Long-term synaptic depression in the striatum: Physiological and pharmacological characterization. J Neurosci 12(11):4224-4233.
11. Centonze D, et al. (1999) Unilateral dopamine denervation blocks corticostriatal LTP. J Neurophysiol 82(6):3575-3579. (Pubitemid 30017476)
12. Paillé V, et al. (2010) Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. J Neurosci 30(42): 14182-14193.
13. Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R (2006) Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 129(Pt 4):1059-1069.
14. Heim C, et al. (2002) Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area: Model of the early beginning of Parkinson's symptomatology? J Neural Transm 109(5-6):691-709. (Pubitemid 34810767)
15. Pisa M (1988) Regional specialization of motor functions in the rat striatum: Implications for the treatment of parkinsonism. Prog Neuropsychopharmacol Biol Psychiatry 12(2-3):217-224.
16. Carlsson T, et al. (2006) Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol Dis 21(3):657-668. (Pubitemid 43277547)
17. Grealish S, et al. (2010) The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain 133(Pt 2):482-495.
18. Lane EL, Vercammen L, Cenci MA, Brundin P (2009) Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats. Exp Neurol 219(1):355-358.
19. Thompson L, Barraud P, Andersson E, Kirik D, Björklund A (2005) Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J Neurosci 25(27):6467-6477. (Pubitemid 40962541)
20. Bagetta V, Ghiglieri V, Sgobio C, Calabresi P, Picconi B (2010) Synaptic dysfunction in Parkinson's disease. Biochem Soc Trans 38(2):493-497.
21. Di Filippo M, et al. (2009) Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory. Behav Brain Res 199(1):108-118.
22. Gardoni F, et al. (2009) Decreased NR2B subunit synaptic levels cause impaired longterm potentiation but not long-term depression. J Neurosci 29(3):669-677.
23. Schotanus SM, Chergui K (2008) Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors. Eur J Neurosci 27(8):1957-1964. (Pubitemid 351521491)
24. Picconi B, et al. (2006) NR2B subunit exerts a critical role in postischemic synaptic plasticity. Stroke 37(7):1895-1901. (Pubitemid 44297748)
25. Picconi B, et al. (2011) Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain 134(Pt 2):375-387.
26. Picconi B, et al. (2003) Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 6(5):501-506. (Pubitemid 36514698)
27. Lane EL, Winkler C, Brundin P, Cenci MA (2006) The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol Dis 22(2):334-345.
28. Carlsson T, Carta M, Winkler C, Björklund A, Kirik D (2007) Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J Neurosci 27(30):8011-8022. (Pubitemid 47173327)
29. Shin E, Garcia J, Winkler C, Björklund A, Carta M (2012) Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease. Neurobiol Dis 47(3):393-406.
30. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39(5): 777-787. (Pubitemid 30103682)
31. Lundblad M, et al. (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 15(1): 120-132. (Pubitemid 35478015)
32. Lindvall O, Kokaia Z (2009) Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 30(5):260-267.
33. Lane EL, Björklund A, Dunnett SB, Winkler C (2010) Neural grafting in Parkinson's disease unraveling the mechanisms underlying graft-induced dyskinesia. Prog Brain Res 184:295-309.
34. Brundin P, Kordower JH (2012) Neuropathology in transplants in Parkinson's disease: Implications for disease pathogenesis and the future of cell therapy. Prog Brain Res 200:221-241.
35. Bagetta V, et al. (2012) Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease. J Neurosci 32(49):17921-17931.
36. Partridge JG, Tang KC, Lovinger DM (2000) Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol 84(3):1422-1429.
37. Kombian SB, Malenka RC (1994) Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor- mediated responses in the nucleus accumbens. Nature 368(6468):242-246. (Pubitemid 24108840)
38. Schramm NL, Egli RE, Winder DG (2002) LTP in the mouse nucleus accumbens is developmentally regulated. Synapse 45(4):213-219. (Pubitemid 34827554)
39. Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM (2004) Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27(8): 468-474. (Pubitemid 38951039)
40. Crittenden JR, Graybiel AM (2011) Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front Neuroanat 5:59.
41. Kawaguchi Y, Wilson CJ, Emson PC (1989) Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J Neurophysiol 62(5):1052-1068. (Pubitemid 19278427)
42. Gerfen CR (1992) The neostriatal mosaic: Multiple levels of compartmental organization. J Neural Transm Suppl 36:43-59.
43. Philpot BD, et al. (2001) Effect of transgenic overexpression of NR2B on NMDA receptor function and synaptic plasticity in visual cortex. Neuropharmacology 41(6): 762-770. (Pubitemid 32972194)
44. Barth AL, Malenka RC (2001) NMDAR EPSC kinetics do not regulate the critical period for LTP at thalamocortical synapses. Nat Neurosci 4(3):235-236. (Pubitemid 32194868)
45. Gardoni F, et al. (2006) A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci 26(11):2914-2922.
46. Nash JE, et al. (2000) Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease. Exp Neurol 165(1):136-142.
47. Philpot BD, Sekhar AK, Shouval HZ, Bear MF (2001) Visual experience and deprivation bidirectionally modify the composition and function of NMDA receptors in visual cortex. Neuron 29(1):157-169. (Pubitemid 32108729)
48. Tang Q, et al. (1999) High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors. J Pharmacol Exp Ther 291(2):760-765. (Pubitemid 29503550)
49. Di Loreto S, et al. (1996) Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat. Exp Neurol 138(2):318-326.
50. Strömberg I, Kehr J, Fuxe K (2000) Restoration of dopamine transmission in graft reinnervated striatum. Evidence for regulation of dopamine D2 receptor function in regions lacking dopamine. Prog Brain Res 125:309-315.
51. Mazzocchi-Jones D, Döbrössy M, Dunnett SB (2009) Embryonic striatal grafts restore bi-directional synaptic plasticity in a rodent model of Huntington's disease. Eur J Neurosci 30(11):2134-2142.
52. Soderstrom KE, et al. (2008) The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors. Neurobiol Dis 32(2):229-242.
53. Piccini P, et al. (2000) Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 48(5):689-695.
54. Annett LE, Torres EM, Ridley RM, Baker HF, Dunnett SB (1995) A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions. Exp Brain Res 103(3):355-371.
55. Clarke DJ, Dunnett SB, Isacson O, Sirinathsinghji DJ, Björklund A (1988) Striatal grafts in rats with unilateral neostriatal lesions. I. Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway. Neuroscience 24(3):791-801.
56. Politis M, et al. (2010) Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med 2(38):38ra46.
57. Ma Y, et al. (2010) Dopamine cell implantation in Parkinson's disease: Long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med 51(1):7-15.
58. Björklund A, Lindvall O (2000) Cell replacement therapies for central nervous system disorders. Nat Neurosci 3(6):537-544.
59. Hagell P, et al. (1999) Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft. Brain 122(Pt 6):1121-1132. (Pubitemid 29533127)
60. Brundin P, et al. (2000) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123(Pt 7): 1380-1390. (Pubitemid 30420938)
61. Widner H, et al. (1992) Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). N Engl J Med 327(22):1556-1563.
62. Hauser RA, et al. (1999) Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 56(2):179-187. (Pubitemid 29076182)
63. Defer GL, et al. (1996) Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119(Pt 1):41-50.
64. Olanow CW, et al. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54(3):403-414. (Pubitemid 37072046)
65. Freed CR, et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344(10):710-719. (Pubitemid 32204988)
66. Brundin P, Barker RA, Parmar M (2010) Neural grafting in Parkinson's disease Problems and possibilities. Prog Brain Res 184:265-294.
67. Forni C, et al. (1989) Time-course of recovery of dopamine neuron activity during reinnervation of the denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltammetry. Exp Brain Res 76(1):75-87. (Pubitemid 19167220)
68. Maries E, et al. (2006) Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol Dis 21(1):165-180. (Pubitemid 41817316)
69. Ma Y, et al. (2002) Dyskinesia after fetal cell transplantation for parkinsonism: A PET study. Ann Neurol 52(5):628-634. (Pubitemid 35246867)
70. Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A (2010) Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson' s disease. Mov Disord 25(Suppl 1):S174-S179.
71. Mahalik TJ, Clayton GH (1991) Specific outgrowth from neurons of ventral mesencephalic grafts to the catecholamine-depleted striatum of adult hosts. Exp Neurol 113(1):18-27.
72. Politis M, et al. (2011) Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio. Mov Disord 26(11):1997-2003.
73. Cenci MA, Lee CS, Björklund A (1998) L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 10(8):2694-2706. (Pubitemid 28362576)
74. Westin JE, Vercammen L, Strome EM, Konradi C, Cenci MA (2007) Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol Psychiatry 62(7):800-810. (Pubitemid 47374647)
75. Winkler C, Kirik D, Björklund A, Cenci MA (2002) L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: Relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 10(2):165-186. (Pubitemid 34775470)
76. Paxinos G (2004) The Rat Nervous System (Elsevier, Amsterdam), 3rd Ed.